DE60138733D1 - Arzneimittel zur behandlung und vermeidung neurogener schmerzen - Google Patents
Arzneimittel zur behandlung und vermeidung neurogener schmerzenInfo
- Publication number
- DE60138733D1 DE60138733D1 DE60138733T DE60138733T DE60138733D1 DE 60138733 D1 DE60138733 D1 DE 60138733D1 DE 60138733 T DE60138733 T DE 60138733T DE 60138733 T DE60138733 T DE 60138733T DE 60138733 D1 DE60138733 D1 DE 60138733D1
- Authority
- DE
- Germany
- Prior art keywords
- medicament
- prevention
- treatment
- neurogenic pain
- neurogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000400679 | 2000-12-28 | ||
PCT/JP2001/011356 WO2002053153A1 (fr) | 2000-12-28 | 2001-12-25 | Medicaments permettant de traiter et de prevenir une douleur neurologique |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60138733D1 true DE60138733D1 (de) | 2009-06-25 |
Family
ID=18865226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60138733T Expired - Lifetime DE60138733D1 (de) | 2000-12-28 | 2001-12-25 | Arzneimittel zur behandlung und vermeidung neurogener schmerzen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7608636B2 (de) |
EP (1) | EP1356812B1 (de) |
JP (1) | JPWO2002053153A1 (de) |
KR (1) | KR100823668B1 (de) |
CN (1) | CN1484527A (de) |
AR (1) | AR032066A1 (de) |
AT (1) | ATE431142T1 (de) |
CA (1) | CA2433039C (de) |
DE (1) | DE60138733D1 (de) |
MX (1) | MXPA03005889A (de) |
WO (1) | WO2002053153A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089410A1 (ja) * | 2003-04-03 | 2004-10-21 | Kyowa Hakko Kogyo Co., Ltd. | 神経因性疼痛の予防及び/または治療剤 |
US7283839B2 (en) | 2004-04-14 | 2007-10-16 | Curitel Communications, Inc. | Wireless communicating terminal for providing integrated messaging service and method thereof |
US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
ITMI20070770A1 (it) * | 2007-04-16 | 2008-10-17 | Brane Discovery S R L | Impiego di dimiracetam nel trattamento del dolore cronico |
AU2009303834B2 (en) * | 2008-10-16 | 2016-08-11 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2011048208A1 (en) * | 2009-10-22 | 2011-04-28 | University College Dublin, National University Of Ireland, Dublin | Causal therapy of diseases or conditions associated with cns or pns demyelination |
PL389364A1 (pl) | 2009-10-23 | 2011-04-26 | Uniwersytet Jagielloński | Nowe zastosowanie pochodnych 2-pirolidonu |
LV14346B (lv) * | 2009-11-05 | 2011-07-20 | Grindeks, A/S | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti |
BR112012019923A2 (pt) * | 2010-02-09 | 2016-08-09 | Univ Johns Hopkins | métodos e composições para melhorar a função cognitiva |
US9662347B2 (en) | 2010-05-11 | 2017-05-30 | Gachon University Of Industry-Academic Cooperation Foundation | Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
EP3827820A1 (de) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam zur verbesserung der kognitiven funktion |
US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
CN112843005B (zh) | 2015-05-22 | 2023-02-21 | 艾吉因生物股份有限公司 | 左乙拉西坦的延时释放药物组合物 |
PL244071B1 (pl) * | 2019-01-07 | 2023-11-27 | Univ Jagiellonski | Pochodne (2,5-dioksopirolidyn-1-ylo)(fenylo)-acetamidu i ich zastosowanie do leczenia chorób o podłożu neurologicznym |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1039113A (en) | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
JPS4219093Y1 (de) | 1965-11-27 | 1967-11-04 | ||
IT1045043B (it) | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
US4118393A (en) * | 1977-06-23 | 1978-10-03 | American Cyanamid Company | Phenyl azabicyclohexanones |
CU21107A3 (es) | 1978-02-10 | 1988-02-01 | Hoffmann La Roche | Pyrrolidines derivatives |
IT1141287B (it) | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
DE2923975A1 (de) | 1979-06-13 | 1980-12-18 | Nattermann A & Cie | Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel |
CH657527A5 (de) * | 1980-02-13 | 1986-09-15 | Ciba Geigy Ag | Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist. |
US4431641A (en) | 1980-10-17 | 1984-02-14 | Ciba-Geigy Corporation | Pharmaceutical compositions having antiepileptic and antineuralgic action |
GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
JPS625404A (ja) | 1985-07-01 | 1987-01-12 | Shinko Electric Co Ltd | 信号レベル変換装置 |
GB8609033D0 (en) | 1986-04-14 | 1986-05-21 | Ucb Sa | Pharmaceutical compositions |
IT1231477B (it) | 1989-07-12 | 1991-12-07 | Sigma Tau Ind Farmaceuti | (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
JPH0779442B2 (ja) | 1989-07-14 | 1995-08-23 | 日本テレビ放送網株式会社 | 雑音減少回路 |
JPH04160496A (ja) | 1990-10-23 | 1992-06-03 | Sharp Corp | 自動販売機の物品搬出機構 |
US5232700A (en) * | 1990-11-14 | 1993-08-03 | The Administrators Of The Tulane Educational Fund | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
JPH04219093A (ja) | 1990-12-19 | 1992-08-10 | Matsushita Electric Ind Co Ltd | 磁気記録再生装置 |
CA2067614C (en) | 1991-05-02 | 2002-07-30 | Eiichi Otomo | Agent for improving dementia |
JP3388778B2 (ja) | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
ZA923134B (en) | 1991-05-02 | 1993-01-27 | Daiichi Seiyaku Co | Agent for improving dementia |
NO179903C (no) | 1992-06-19 | 1997-01-08 | Daiichi Seiyaku Co | Fremgangsmåte for fremstilling av et halogenacetamidderivat samt et pyrrolidinylacetamidderivat |
GB9505692D0 (en) * | 1995-03-21 | 1995-05-10 | Glaxo Group Ltd | Chemical compounds |
US5885976A (en) * | 1995-05-08 | 1999-03-23 | Sandyk; Reuven | Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions |
US6116270A (en) * | 1995-08-04 | 2000-09-12 | Hydro-Flo Holdings Pty Ltd. | Piston valve |
US6107330A (en) | 1995-08-07 | 2000-08-22 | Daiichi Pharmaceutical Co., Ltd. | Inhibitor for narcotic analgesic dependence/resistance acquisition |
US5551846A (en) | 1995-12-01 | 1996-09-03 | Ford Motor Company | Scroll compressor capacity control valve |
EP0953356A4 (de) | 1996-10-01 | 2002-04-17 | Daiichi Seiyaku Co | Mitochondrialen membrane stabilisator |
DE69823851D1 (de) | 1997-07-15 | 2004-06-17 | Daiichi Seiyaku Co | Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund |
TW544311B (en) | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
US20040077709A1 (en) * | 1999-05-31 | 2004-04-22 | Daiichi Pharmaceutical Co., Ltd. | Neuronal death inhibitors |
CA2374921A1 (en) | 1999-05-31 | 2000-12-07 | Shigeo Watabe | Neuronal death inhibitors |
US6349442B1 (en) * | 1999-06-23 | 2002-02-26 | Advanced Prosthetic Technologies, Inc. | Brush tip for a motorized toothbrush |
SK7492002A3 (en) * | 1999-12-01 | 2003-02-04 | Ucb Sa | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
US6423739B1 (en) * | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
-
2001
- 2001-12-25 KR KR1020037008668A patent/KR100823668B1/ko not_active IP Right Cessation
- 2001-12-25 DE DE60138733T patent/DE60138733D1/de not_active Expired - Lifetime
- 2001-12-25 AT AT01272527T patent/ATE431142T1/de not_active IP Right Cessation
- 2001-12-25 JP JP2002554103A patent/JPWO2002053153A1/ja active Pending
- 2001-12-25 WO PCT/JP2001/011356 patent/WO2002053153A1/ja active Application Filing
- 2001-12-25 EP EP01272527A patent/EP1356812B1/de not_active Expired - Lifetime
- 2001-12-25 CN CNA018216242A patent/CN1484527A/zh active Pending
- 2001-12-25 CA CA2433039A patent/CA2433039C/en not_active Expired - Fee Related
- 2001-12-25 MX MXPA03005889A patent/MXPA03005889A/es not_active Application Discontinuation
- 2001-12-25 US US10/450,524 patent/US7608636B2/en not_active Expired - Fee Related
- 2001-12-27 AR ARP010106055A patent/AR032066A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2433039C (en) | 2010-06-08 |
WO2002053153A1 (fr) | 2002-07-11 |
JPWO2002053153A1 (ja) | 2004-04-30 |
KR20040025882A (ko) | 2004-03-26 |
ATE431142T1 (de) | 2009-05-15 |
EP1356812B1 (de) | 2009-05-13 |
AR032066A1 (es) | 2003-10-22 |
CA2433039A1 (en) | 2002-07-11 |
US20040063776A1 (en) | 2004-04-01 |
KR100823668B1 (ko) | 2008-04-21 |
EP1356812A4 (de) | 2006-04-12 |
MXPA03005889A (es) | 2005-02-14 |
US7608636B2 (en) | 2009-10-27 |
EP1356812A1 (de) | 2003-10-29 |
CN1484527A (zh) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE434444T1 (de) | Vorbeugung und behandlung von amyloidogenischen krankheiten | |
DE60109589D1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
DE60121992D1 (de) | Zusammensetzung zur verabreichung und beschichtung medizinischer geräte | |
DE60109044D1 (de) | Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
DE69830728D1 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
DE60138733D1 (de) | Arzneimittel zur behandlung und vermeidung neurogener schmerzen | |
HUP0302476A3 (en) | Use of acetylcholinesterase inhibitors and gabaainverse agonists for the treatment of cognitive disorders and for preparation of pharmaceutical compositins | |
DE69802260D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen | |
AR028426A1 (es) | Una composicion farmaceutica y procedimiento de tratamiento de enfermedades de disfunsion cognitiva en un mamifero | |
DE122006000035I1 (de) | D2-Agonist enthaltendes transdermales Therapeutisches System zur Behandlung des Parkinson-syndroms und Berfahren zu seiner Herstellung | |
NO20014046D0 (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
DE69806801T2 (de) | Galenische präparation zur prävention und behandlung von hepatokarzinomen | |
DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
DE60027209D1 (de) | Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen | |
DE60132851D1 (de) | Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension | |
DE69925488D1 (de) | Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
DE60139783D1 (de) | Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen | |
DE60107034D1 (de) | Misch- und Ladeöffnung zur medizinischen Behandlung | |
ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
ATE400277T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
ATE314064T1 (de) | L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |